Zai Lab Ltd banner

Zai Lab Ltd
HKEX:2925

Watchlist Manager
Zai Lab Ltd Logo
Zai Lab Ltd
HKEX:2925
Watchlist
Price: 0.22 HKD Market Closed
Market Cap: HK$5.1B

Multiples-Based Value

2925 price has not been updated for more than 4 years. This may indicate that the stock has been delisted.

The Multiples-Based Value of one Zai Lab Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.22 HKD, Zai Lab Ltd is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Zai Lab Ltd Multiples-Based Value
LOCKED
Unlock
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Zai Lab Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zai Lab Ltd
HKEX:2925
17.5B HKD 5.1 -13.3 -9.1 -8.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
364.8B USD 6.1 88.7 14.7 20.4
US
Amgen Inc
NASDAQ:AMGN
183.3B USD 5.1 24.2 14.1 14.1
US
Gilead Sciences Inc
NASDAQ:GILD
172.3B USD 5.9 20.4 12.8 15.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.7B USD 9.3 28.2 21.2 22.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD 5.7 18 13.5 15.4
AU
CSL Ltd
ASX:CSL
67.6B AUD 3 33.6 11.3 14.2
NL
argenx SE
XBRU:ARGX
39.7B EUR 11.6 37.3 40.7 41.5
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.8 -66.6 -60.1
P/S Multiple
Revenue Growth P/S to Growth
CN
Zai Lab Ltd
HKEX:2925
Average P/S: 3 063 003.3
5.1
22%
0.2
FR
Pharnext SCA
OTC:PNEXF
33 690 872.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.1
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.1
3%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
5.9
5%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.3
11%
0.8
US
E
Epizyme Inc
F:EPE
2 091
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
10%
0.6
AU
CSL Ltd
ASX:CSL
3
4%
0.8
NL
argenx SE
XBRU:ARGX
11.6
28%
0.4
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
P/E Multiple
Earnings Growth PEG
CN
Zai Lab Ltd
HKEX:2925
Average P/E: 35.8
Negative Multiple: -13.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
88.7
97%
0.9
US
Amgen Inc
NASDAQ:AMGN
24.2
20%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
20.4
16%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
17%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
13%
1.4
AU
CSL Ltd
ASX:CSL
33.6
10%
3.4
NL
argenx SE
XBRU:ARGX
37.3
32%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Zai Lab Ltd
HKEX:2925
Average EV/EBITDA: 18.3
Negative Multiple: -9.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
14.7
12%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.1
10%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
9%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.2
16%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
18%
0.7
AU
CSL Ltd
ASX:CSL
11.3
7%
1.6
NL
argenx SE
XBRU:ARGX
40.7
50%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Zai Lab Ltd
HKEX:2925
Average EV/EBIT: 20.5
Negative Multiple: -8.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
20.4
23%
0.9
US
Amgen Inc
NASDAQ:AMGN
14.1
3%
4.7
US
Gilead Sciences Inc
NASDAQ:GILD
15.8
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
17%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
23%
0.7
AU
CSL Ltd
ASX:CSL
14.2
10%
1.4
NL
argenx SE
XBRU:ARGX
41.5
51%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett